COPD EXACERBATIONS IN OLDER PERSONS
|
|
- Alyson Bryant
- 7 years ago
- Views:
Transcription
1 COPD EXACERBATIONS IN OLDER PERSONS Carlos Fragoso, MD Yale University School of Medicine VA Connecticut Healthcare System No Conflicts of Interest
2 True or False Re. COPD exacerbations Age is a predisposing factor Sputum analysis should be performed routinely Respiratory failure is the most common cause of death
3 Outline Epidemiology Risk Factors Pathophysiology Management Follow-Up ATS/ERS Guidelines: GOLD Guidelines: Am J Respir Crit Care Med 2007;176: The 2009 report is available online at CTS COPD guidelines: Can Respir J 2007;14 (Suppl B):5B-32B.
4 Epidemiology Definition A COPD exacerbation refers to acute worsening of respiratory symptoms,* requiring a change in management * Up to 50% may go unreported Cardinal symptoms: dyspnea, sputum purulence/volume Mild exacerbation: one cardinal symptom Moderate exacerbation: 2 of 3 cardinal symptoms Severe exacerbation: 3 cardinal symptoms Plus one or more of the following: URI, fever, wheezing or coughing, or RR or HR.
5 Epidemiology Outcomes COPD accounts for over 500,000 hospitalizations (USA) High relapse rates: 1/3 rd of patients discharged from the ED have recurrent symptoms within 2-weeks, requiring hospitalization in 17% Of those hospitalized in hypercapneic respiratory failure, about 50% will be readmitted within 6 months High morbidity and mortality: For those requiring an ICU admission, there are progressive decrements in functional status and quality of life, with mortality rates of 30-50%
6 Outline Epidemiology Risk Factors Pathophysiology Management Follow-Up
7 Predisposing Factors Age Multimorbidity Low physical activity Low SES Chronic bronchitis Low FEV1 Chronic respiratory failure Escalating use of bronchodilators or corticosteroids Prior exacerbation (ED, hospitalization)
8 Aging as a predisposing factor AJRCCM 2008;177: Associated with airflow limitation and air trapping
9 Aging as a predisposing factor Two-thirds of older persons have 2 or more chronic conditions
10 Aging as a predisposing factor
11 MMWR 2008; 57(45): Aging as a predisposing factor
12 Precipitating Factors Infection: ~ 60% Bacteria: S pneumoniae, H influenzae, M catarrhalis, Enterobactericae, P aeruginosa Viruses: Rhinovirus, Influenza, Parainfluenza, RSV, Coronavirus Pollutants: ~ 10% Ozone, sulphur dioxide, nitrogen dioxide, particulate matter, biomass fuels Unknown: ~ 30%
13 Precipitating Factors Prevalence of chronic bronchitis relative to active smoking Eur Respir Mono 2006;38:41-70.
14 Precipitating Factors AJRCCM 2001;164: Physician visits in the continuous smoking group
15 AJRCCM 2002;166; Precipitating Factors
16 Thorax 2006;61; Precipitating Factors
17 Perpetuating Factors Depression and anxiety adds to disability caused by physical illness reduces adherence to medications risk factor for cognitive decline prolongs COPD exacerbations increases frequency of hospital admissions Int J Geriatr Psychiatry 2000; 15: Int J Geriatr Psychiatry 1997; 12:
18 Outline Epidemiology Risk Factors Pathophysiology Management Follow-Up
19 Pathophysiology Baseline Small airways and alveolar destruction, with pulmonary vascular remodeling Sarcopenia and reduced central respiratory drive
20 Pathophysiology Exacerbation airway inflammation, mucous hypersecretion, and bronchoconstriction, resulting in impaired gas exchange and respiratory muscle fatigue
21 Pathophysiology Comorbidities In one autopsy-based study, of 43 decedents hospitalized with a COPD exacerbation (median age 70), the cause of death was heart failure in 16 (37%), pneumonia in 12 (28%), thromboembolism in 9 (21%), but respiratory failure in only 6 (16%). Of the decedents, 33 (77%) had 1 or more comorbidities, with the most common being chronic heart failure (25; 58%). Chest 2009;136:
22 Outline Epidemiology Risk Factors Pathophysiology Management Follow-Up
23 Management Admission Criteria Marked increase in dyspnea, associated with changes in vital signs, cyanosis, or peripheral edema Severe COPD: FEV1<50%Pred, chronic respiratory failure, prior exacerbations Arrhythmias Comorbidities Older age Inadequate home support
24 Management ICU Criteria Severe dyspnea refractory to initial emergency therapy Change in mental status (delirium) Severe respiratory failure: PaCO2 >60 torr, ph <7.25 Hemodynamic instability
25 Management Evaluation CBC, CHEM7, theophylline level (if on medication) ABG if no prompt improvement in response to initial Rx ECG CXR Blood cultures if febrile Sputum gram stain and culture if poor response to empiric antibiotics or pseudomonas is suspected does not distinguish pathogens versus colonizing flora
26 Management Bronchodilators A short-acting beta-2 agonist is effective (Evidence A) with or without an anticholinergic (Evidence B) Albuterol: 2.5 mg by nebulizer every one to four hours, or 4 to 8 puffs (90 mcg/puff) by MDI with a spacer every one to four hours. Ipratropium: 500 mcg by nebulizer every four hours, or 2 puffs (18 mcg/puff) by MDI with a spacer every four hours. Methylxanthines: controversial Limited efficacy in COPD exacerbations, side effects
27 Management Steroids Effective treatment for exacerbations; recovery time, FEV1, PaO2 (Evidence A) Prednisone mg po per day for 7-14 days. Methylprednisolone mg IV Q6H (3 days), followed by prednisone (60, 40, and 20-mg po QD, each for 4-days) NEJM 1999;340:
28 Management Antibiotics Antibiotics may be useful, if the exacerbation is associated with dyspnea and sputum purulence or volume (moderateto-severe), or requires mechanical ventilation (Evidence B) H influenza, S pneumoniae, M catarrhalis, C pneumoniae Beta-lactamase resistant species Enterobacteriaceae P aeruginosa Antibiotics based on local resistance patterns No role for mucolytics or chest PT
29 Management Antibiotics If <65 years, FEV1 >50% Pred, no prior Abx, no comorbidity Advanced macrolide (azithromycin), or doxycycline, or cephalosporin (cefuroxime), or trimethoprin/sulfamethoxazole. If >65 years, FEV1 <50% Pred, prior Abx, comorbidity Respiratory fluoroquinolone (gatifloxacin, levofloxacin, moxifloxacin) or amoxicillin/clavulanate. Consider sputum analysis, if worsening clinical status or inadequate response in 72-hrs.
30 Management Antibiotics Suspect P aeruginosa: prior isolation, recent Abx use or hospitalization, FEV1 <50%Pred, and/or systemic steroid use order sputum gram stain and culture consider dual antibiotic therapy: levofloxacin, ciprofloxacin, piperacillin-tazobactam, cefepime, and/or ceftazidine.
31 Management Oxygen Adequate oxygenation (PaO torr, SpO %) Prevention of hypoxia trumps CO2 retention concerns Venturi mask: delivers a precise FiO2 of 24, 28, 31, 35, 40, 50, or 60%; FiO2 gradually monitor PaO2 & PaCO2.
32 Management Oxygen Nasal cannula can provide up to 40% FiO2 (6 L/min) Variations in ventilation and entrainment of RA affect FiO2 Simple facemask can provide up to 55% FiO2 (6-10 L/min) Variations in ventilation and entrainment of RA affect FiO2 Non-rebreathing masks with a reservoir, one-way valves, and tight seal can deliver up to 90% FiO2. suspect comorbidity if high FiO2 required (HF, PNA, PE)
33 Management Noninvasive Ventilation Improves respiratory acidosis and dyspnea, and decreases intubation rates, length of hospitalization, and mortality (Evidence A) Selection criteria: Moderate to severe dyspnea (use of accessory muscles, paradoxical abdominal motion, >25 breaths/min) Hypercapneic respiratory failure: ph <7.35, PaCO2 >45 torr Settings: CPAP (4 8 cmh2o) and PSV (10 15 cmh2o) provides the most effective mode of NIV
34 Management Noninvasive Ventilation Exclusion Criteria: Respiratory arrest Cardiovascular instability (hypotension, arrhythmias, ACS) Delirium (uncooperative) Secretions (viscous, copious) High aspiration risk Craniofacial trauma Nasopharyngeal abnormalities Burns Extreme obesity
35 Management Comorbidities Monitor fluid balance and nutrition DVT prophylaxis Identify and manage associated conditions heart failure, arrhythmias, pneumonia, pulmonary embolism
36 Management Hospital Discharge ABG stable for 24-hours Clinically stable for 24-hours Able to eat and sleep w/o frequent disruption by dyspnea If previously ambulatory, able to walk across room Beta-2 agonist no more frequent than every 4-hours Home follow-up Patient/caregiver understand treatment plan Referrals completed (VNA, O2, nebulizer, meals, etc)
37 Home-Based Management Ram et al. HOSPITAL AT HOME FOR PATIENTS WITH ACUTE EXACERBATIONS OF COPD: systematic review of evidence. BMJ 2004; 329: studies: randomized to hospital-at-home or inpatient No difference in readmission or mortality rates; less costly. Exclusion criteria for hospital-at-home : Impaired consciousness Acute changes on radiography or ECG Arterial ph < 7.35 Comorbidities Social problems
38 Outline Epidemiology Risk Factors Pathophysiology Management Follow-Up
39 Follow-up Respiratory At 4-6 weeks post discharge Revisit smoking status Review vaccination status Spirometry Reinforce inhaler technique Tiotropium and combined [beta-2 agonist and CS] Assess need for home oxygen and nebulizer Evaluate understanding of treatment regimen review written action plan for exacerbations
40 Follow-up Comprehensive
41 Follow-up Pulmonary Rehab Benefits include (Evidence A) Improves dyspnea and exercise capacity Improves health-related quality of life Reduces number and duration of hospitalizations
42 Geriatrics-based providers are uniquely qualified to coordinate the care of older persons with COPD, given their expertise in multimorbidity and geriatric syndromes. Pulmonary consultation should be sought in the setting of escalating respiratory symptoms and/or respiratory failure
43 Re. COPD exacerbations Age is a predisposing factor TRUE Sputum analysis should be performed routinely FALSE Respiratory failure is the most common cause of death FALSE
PLAN OF ACTION FOR. Physician Name Signature License Date
PLAN OF ACTION FOR Patient s copy (patient s name) I Feel Well Lignes I feel short directrices of breath: I cough up sputum daily. No Yes, colour: I cough regularly. No Yes I Feel Worse I have changes
More informationThe patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
More informationManagement of exacerbations in chronic obstructive pulmonary disease in Primary Care
Management of exacerbations in chronic obstructive pulmonary disease in Primary Care Acute exacerbations of chronic obstructive pulmonary disease (COPD) are associated with significant morbidity and mortality.
More informationPrevention of Acute COPD exacerbations
December 3, 2015 Prevention of Acute COPD exacerbations George Pyrgos MD 1 Disclosures No funding received for this presentation I have previously conducted clinical trials with Boehringer Ingelheim. Principal
More informationIrish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy
31 st Irish Association for Emergency Medicine (IAEM) submission to the National COPD Strategy 1 Introduction Chronic obstructive pulmonary disease (COPD) is an important disease for patients, the health
More informationCLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
More informationCOPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
More informationNICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.
bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.
More informationObjectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011
Objectives Discuss assessment findings and treatment for: Chronic Obstructive Pulmonary Disease Bronchitis Emphysema Asthma Anaphylaxis Other respiratory issues Provide some definitions Chronic Obstructive
More informationMarilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL
Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT
More informationOxygenation. Chapter 21. Anatomy and Physiology of Breathing. Anatomy and Physiology of Breathing*
Oxygenation Chapter 21 Anatomy and Physiology of Breathing Inspiration ~ breathing in Expiration ~ breathing out Ventilation ~ Movement of air in & out of the lungs Respiration ~ exchange of O2 & carbon
More informationRES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP
RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families
More informationChronic Obstructive Pulmonary Disease (COPD) Admission Order Set
Patient Name: PHN: Page 1/1 Admit to Dr: Notified Consult: Dr: Family Dr: Precautions: Contact Droplet Enhanced Droplet Airborne - Reason: _ Code Status: Full Resuscitation or Consults: Reason: Dietician
More informationPathway for Diagnosing COPD
Pathway for Diagnosing Visit 1 Registry Clients at Risk Patient presents with symptoms suggestive of Exertional breathlessness Chronic cough Regular sputum production Frequent bronchitis ; wheeze Occupational
More informationExploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway. Health Quality Ontario s integrated episode of care for COPD
Exploring the Chronic Obstructive Pulmonary Disease (COPD) Clinical Pathway Health Quality Ontario s integrated episode of care for COPD Dr. Charlie Chan Health Quality Ontario Expert Panel Co-Chair May/June
More informationPulmonary Diseases. Lung Disease: Pathophysiology, Medical and Exercise Programming. Overview of Pathophysiology
Lung Disease: Pathophysiology, Medical and Exercise Programming Overview of Pathophysiology Ventilatory Impairments Increased airway resistance Reduced compliance Increased work of breathing Ventilatory
More informationUnderstanding COPD. Carolinas Healthcare System
Understanding COPD Carolinas Healthcare System 2013 This self-directed learning module contains information about the pathophysiology, diagnosis, and treatment of COPD. Target Audience: All RNs and LPNs
More informationHow To Treat Acute Bronchitis
Bronchitis in Adults and Children Kristen Lewis, MD Acute Bronchitis Cough, with or without phlegm Lasting less than 3 weeks Frequently associated with or preceded d by other upper respiratory symptoms
More informationImportance of Protocols in the Decision to Use Noninvasive Ventilation
Importance of Protocols in the Decision to Use Noninvasive Ventilation Janice L. Zimmerman, M.D. Weill Cornell Medical College The Methodist Hospital Houston, Texas Objectives Review application of protocols
More informationOriginal Article COPD and Hospital Stay Pak Armed Forces Med J 2014; 64 (1): 46-50. Ahmed Raza, Mahmood Iqbal Malik*, Yousaf Jamal**
Original Article COPD and Hospital Stay Pak Armed Forces Med J 2014; 64 (1): 46-50 COMPARISON OF NIPPV WITH STANDARD TREATMENT IN PATIENTS WITH ACUTE EXACERBATIONS OF COPD IN TERMS OF IMPROVEMENT IN ABGS
More informationIN-HOME QUALITY IMPROVEMENT. BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK
IN-HOME QUALITY IMPROVEMENT BEST PRACTICE: DISEASE MANAGEMENT Chronic Obstructive Pulmonary Disease NURSE TRACK Best Practice Intervention Packages were designed for use by any In-Home Provider Agency
More informationNational Learning Objectives for COPD Educators
National Learning Objectives for COPD Educators National Learning Objectives for COPD Educators The COPD Educator will be able to achieve the following objectives. Performance objectives, denoted by the
More informationJames F. Kravec, M.D., F.A.C.P
James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice
More informationChronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
More informationCOPD Intervention. Components:
COPD Intervention 1. Primary disease education Member will have an increased understanding of chronic obstructive pulmonary disease, the causes, risks and complications. Explain COPD Explain how COPD is
More informationPulmonary Rehabilitation in Newark and Sherwood
Pulmonary Rehabilitation in Newark and Sherwood With exception of smoking cessation pulmonary rehabilitation is the single most effective intervention for any patient with COPD. A Cochrane review published
More informationRespiratory failure and Oxygen Therapy
Respiratory failure and Oxygen Therapy A patient with Hb 15 G % will carry 3X more O2 in his blood than someone with Hb 5G % Give Controlled O2 treatment in acute pulmonary oedema to avoid CO2 retention
More informationAECOPD. Guideline for. The Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) 2006 Update
Guideline for Administered by the Alberta Medical Association 2006 Update The Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) AECOPD This clinical practice guideline
More informationHow To Treat A Patient With A Lung Condition
NHS FORTH VALLEY BIPAP Guideline Date of First Issue 27 / 10 / 2010 Approved 27 / 10 / 2010 Current Issue Date 27 / 10 / 2010 Review Date 27 / 10 / 2012 Version Version 1.00 EQIA Yes 27 / 10 / 2010 Author
More informationCOPD MANAGEMENT PROTOCOL STANFORD COORDINATED CARE
I. PURPOSE To establish guidelines f the collabative management of patients with a diagnosis of chronic obstructive pulmonary disease (COPD) who are not adequately controlled and to define the roles and
More informationInpatient Strategies. Hataya Kristy Poonyagariyagorn, MD Oregon Pulmonary Associates
Inpatient Strategies Hataya Kristy Poonyagariyagorn, MD Oregon Pulmonary Associates Medical Director Intensive Care Unit and Respiratory Therapy Department Providence Newberg Medical Center Associate Program
More informationYear in review: mechanical ventilation
Year in review: mechanical ventilation Leo Heunks, MD, PhD Pulmonary and Critical Care Physician Dept of Critical Care Intensivisten dagen 2013 Disclosures Maquet (NAVA catheters, travel fee, speakers
More informationTests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
More informationCompare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma
Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis,
More informationDepartment of Surgery
What is emphysema? 2004 Regents of the University of Michigan Emphysema is a chronic disease of the lungs characterized by thinning and overexpansion of the lung-like blisters (bullae) in the lung tissue.
More informationRespiratory Concerns in Children with Down Syndrome
Respiratory Concerns in Children with Down Syndrome Paul E. Moore, M.D. Associate Professor of Pediatrics and Pharmacology Director, Pediatric Allergy, Immunology, and Pulmonary Medicine Vanderbilt University
More informationPre-Operative Services Teaching Rounds 2 Jan 2011
Pre-Operative Services Teaching Rounds 2 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu
More informationOxygen Therapy. Oxygen therapy quick guide V3 July 2012.
PRESENTATION Oxygen (O 2 ) is a gas provided in a compressed form in a cylinder. It is also available in a liquid form. It is fed via a regulator and flow meter to the patient by means of plastic tubing
More informationBronchodilators in COPD
TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for
More informationBetter Breathing with COPD
Better Breathing with COPD People with Chronic Obstructive Pulmonary Disease (COPD) often benefit from learning different breathing techniques. Pursed Lip Breathing Pursed Lip Breathing (PLB) can be very
More informationAcute Care of COPD: Gaps in our knowledge. Robert A. Wise, M.D. May 20, 2010
Acute Care of COPD: Gaps in our knowledge Robert A. Wise, M.D. May 20, 2010 Outline of talk Importance of COPD exacerbations Current treatments Areas for improvement Significant knowledge gaps Strategies
More informationThe American College of Physicians American Society
CLINICAL PRACTICE GUIDELINE, PART 1 Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Vincenza Snow, MD; Steven Lascher, DVM, MPH; and Christel Mottur-Pilson,
More informationAsthma in Infancy, Childhood and Adolescence. Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California
Asthma in Infancy, Childhood and Adolescence Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California Major Health Problem in Childhood Afflicts 2.7 million children in the USA
More informationAn Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
More informationChronic obstructive pulmonary disease: Management of adults with chronic obstructive pulmonary disease in primary and secondary care
Chronic obstructive pulmonary disease: Management of adults with chronic obstructive pulmonary disease in primary and secondary care NICE guideline First draft for consultation, September 2003 If you wish
More informationAsthma. Micah Long, MD
Asthma Micah Long, MD Goals Define the two components of asthma. Describe the method of action and uses for: Steroids (inhaled and IV) Quick Beta Agonists (Nebs and MDIs) The "Others" Magnesium, Epi IM,
More informationUnderstanding Hypoventilation and Its Treatment by Susan Agrawal
www.complexchild.com Understanding Hypoventilation and Its Treatment by Susan Agrawal Most of us have a general understanding of what the term hyperventilation means, since hyperventilation, also called
More informationWaterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version)
Waterloo Wellington Rehabilitative Care System Integrated Care Pathway for COPD Stream of Care (short version) Care Setting ACUTE Activity Confirmation of COPD diagnoses: If time and the patient s condition
More informationMedications for Managing COPD in Hospice Patients. Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources
Medications for Managing COPD in Hospice Patients Jim Joyner, PharmD, CGP Director of Clinical Operations Outcome Resources Goal of medications in COPD Decrease symptoms and/or complications Reduce frequency
More informationCOPD. (Chronic Obstructive Pulmonary Disease) (Emphysema) (Chronic Bronchitis) Education For Our Community
COPD (Chronic Obstructive Pulmonary Disease) (Emphysema) (Chronic Bronchitis) Education For Our Community Chronic Obstructive Pulmonary Disease (COPD) Definition Chronic obstructive pulmonary disease (COPD)
More informationOXYGEN AND ASSISTED VENTILATION FOR COPD
OXYGEN AND ASSISTED VENTILATION FOR COPD INTERNATIONAL COPD COALITION PHYSICIANS POCKET GUIDE 2011 Aim of this Guide COPD is the fourth leading cause of death in the world, and its prevalence and health
More informationCommon Ventilator Management Issues
Common Ventilator Management Issues William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center You have just admitted a 28 year-old
More informationwritten by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org/copd What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are two major diseases included in
More informationThese factors increase your chance of developing emphysema. Tell your doctor if you have any of these risk factors:
Emphysema Pronounced: em-fiss-see-mah by Debra Wood, RN En Español (Spanish Version) Definition Emphysema is a chronic obstructive disease of the lungs. The lungs contain millions of tiny air sacs called
More information30 DAY COPD READMISSIONS AND PULMONARY REHAB
30 DAY COPD READMISSIONS AND PULMONARY REHAB Trina M. Limberg, Bs, RRT, FAARC, MAACVPR Director, Preventative Pulmonary and Rehabilitation Services UC San Diego Health System OVERVIEW The Impact of COPD
More informationLothian Guideline for Domiciliary Oxygen Therapy Service for COPD
Lothian Guideline for Domiciliary Oxygen Therapy Service for COPD This document describes the standard for clinical assessment, prescription, optimal management and follow-up of patients receiving domiciliary
More informationPulmonary Disorders. Chronic Obstructive Pulmonary Disease (COPD) Chronic Obstructive Pulmonary Disease (COPD)
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Pulmonary Disorders Chronic Obstructive Pulmonary Disease (COPD) Characterized by decreased expiratory airflow Reduction in expiratory
More informationDiabetic Ketoacidosis: When Sugar Isn t Sweet!!!
Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes
More informationOxygen - update April 2009 OXG
PRESENTATION Oxygen (O 2 ) is a gas provided in compressed form in a cylinder. It is also available in liquid form, in a system adapted for ambulance use. It is fed via a regulator and flow meter to the
More informationSouthwark Clinical Commissioning Group Lambeth Clinical Commissioning Group
Getting the Vision Right: A multi-disciplinary approach to providing integrated care for respiratory patients Dr Noel Baxter, GP NHS Southwark CCG Dr Irem Patel, Integrated Consultant Respiratory Physician
More informationReducing COPD Readmissions and Implications for Pulmonary Rehab. Janie Knipper, APN, MA, AE-C, FAACVPR jane-knipper@uiowa.edu
Reducing COPD Readmissions and Implications for Pulmonary Rehab Janie Knipper, APN, MA, AE-C, FAACVPR jane-knipper@uiowa.edu Statement of Disclosure I have no disclosures. The opinions expressed are my
More informationUnderstanding COPD. An educational health series from
Understanding COPD An educational health series from Our Mission since 1899 is to heal, to discover, and to educate as a preeminent healthcare institution. We serve by providing the best integrated and
More informationCOPD exacerbation is a nightmare not only to all clinicians
38 SUPPLEMENT TO JAPI FEBRUARY 2012 VOL. 60 Treatment of Acute Exacerbation of COPD AG Ghoshal 1, Raja Dhar 2, Susmita Kundu 3 COPD exacerbation is a nightmare not only to all clinicians but also for the
More informationACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) S. Agarwal, MD, S. Kache MD
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) S. Agarwal, MD, S. Kache MD Definition ARDS is a clinical syndrome of lung injury with hypoxic respiratory failure caused by intense pulmonary inflammation that
More informationAdult Home Oxygen Therapy. Purpose To provide guidance on the requirements for and procedures relating to domiciliary oxygen therapy.
Contents Purpose... 1 Scope/Audience... 1 Categories for Home Oxygen Therapy... 2 Assessment for Home Oxygen Therapy... 3 Investigations... 3 Requests for home oxygen... 3 Provision of Home Oxygen... 4
More informationMedication and Devices for Chronic Obstructive Pulmonary Disease (COPD)
Medication and Devices for Chronic Obstructive Pulmonary Disease (COPD) Patients with COPD take a wide variety of medicines to manage their symptoms these include: Inhaled Short Acting Bronchodilators
More informationSTATUS ASTHMATICUS S. Agarwal, MD, S. Kache, MD
STATUS ASTHMATICUS S. Agarwal, MD, S. Kache, MD Definition Status asthmaticus is a life-threatening form of asthma in which progressively worsening reactive airways are unresponsive to usual appropriate
More informationEMPHYSEMA THERAPY. Information brochure for valve therapy in the treatment of emphysema.
EMPHYSEMA THERAPY Information brochure for valve therapy in the treatment of emphysema. PATIENTS WITH EMPHYSEMA With every breath, lungs deliver oxygen to the rest of the body to perform essential life
More information3/11/15. COPD Disease Management Tackling the Transition. Objectives. Describe the multidisciplinary approach to inpatient care for COPD patients
Faculty Disclosures COPD Disease Management Tackling the Transition Dr. Cappelluti has no actual or potential conflicts of interest associated with this presentation. Jane Reardon has no actual or potential
More informationCOPD Prescribing Guidelines
South Staffordshire Area Prescribing Group COPD Prescribing Guidelines Inhaler choices in this guideline are different from previous versions produced by the APG. It is not expected patients controlled
More informationNursing college, Second stage Microbiology Dr.Nada Khazal K. Hendi L14: Hospital acquired infection, nosocomial infection
L14: Hospital acquired infection, nosocomial infection Definition A hospital acquired infection, also called a nosocomial infection, is an infection that first appears between 48 hours and four days after
More informationAppendix L: HQO Year 1 Implementation Priorities
Appendix L: HQO Year 1 Implementation Priorities Chronic Obstructive Pulmonary Disease (Source: COPD Chairs) Non-Invasive Positive Pressure Ventilation Early Ambulation If possible, seek patient preferences
More informationClinical guideline Published: 23 June 2010 nice.org.uk/guidance/cg101
Chronic obstructive pulmonary disease in over 16s: diagnosis and management Clinical guideline Published: 23 June 2010 nice.org.uk/guidance/cg101 NICE 2010. All rights reserved. Your responsibility The
More informationHospital-at-Home Programs for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Evidence-Based Analysis
Hospital-at-Home Programs for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): An Evidence-Based Analysis BR McCurdy March 2012 Ontario Health Technology Assessment Series;
More informationKINDRED HEALTHCARE. Billing & Coding for SNF Physician Visits. KINDRED HEALTHCARE Continue the Care
KINDRED HEALTHCARE Billing & Coding for SNF Physician Visits KINDRED HEALTHCARE Continue the Care 1 SNF CPT Codes Initial Care Services 99304 99305 99306 Subsequent Care Services 99307 99308 99309 99310
More informationCOPD It Can Take Your Breath Away www.patientedu.org
written by Harvard Medical School COPD It Can Take Your Breath Away www.patientedu.org What Is COPD? COPD stands for chronic obstructive pulmonary disease. There are 2 major diseases included in COPD:
More informationSign up to receive ATOTW weekly - email worldanaesthesia@mac.com
ANAESTHESIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ANAESTHESIA TUTORIAL OF THE WEEK 106 28 TH JULY 2008 Dr. Mai Wakatsuki Dr Tom Havelock SELF-ASSESSMENT Please answer questions 1-3 true
More informationU.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
Guidance for Industry Acute Bacterial Exacerbations of Chronic Bronchitis in Patients With Chronic Obstructive Pulmonary Disease: Developing Antimicrobial Drugs for Treatment U.S. Department of Health
More informationNon-Invasive Positive Pressure Ventilation in Heart Failure Patients: For Who, Wy & When?
REUNIÃO CONJUNTA DOS GRUPOS DE ESTUDO DE CUIDADOS INTENSIVOS CARDÍACOS E DE FISIOPATOLOGIA DO ESFORÇO E REABILITAÇÃO CARDÍACA O L H Ã O 2 7 e 2 8 d e J a n e i r o 2 0 1 2 Non-Invasive Positive Pressure
More informationPneumonia Education and Discharge Instructions
Pneumonia Education and Discharge Instructions Pneumonia Education and Discharge Instructions Definition: Pneumonia is an infection of the lungs. Many different organisms can cause it, including bacteria,
More informationUsing home NIV for the management of hypercapnic COPD
Home NIV Program for COPD Using home NIV for the management of hypercapnic COPD This program offers COPD treatment guidelines to physicians to help appropriately target and qualify patients for noninvasive
More informationInpatient Heart Failure Management: Risks & Benefits
Inpatient Heart Failure Management: Risks & Benefits Dr. Kenneth L. Baughman Professor of Medicine Harvard Medical School Director, Advanced Heart Disease Section Brigham & Women's Hospital Harvard Medical
More informationCOPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
More informationSE5h, Sepsis Education.pdf. Surviving Sepsis
Surviving Sepsis 1 Scope and Impact of the Problem: Severe sepsis is a major healthcare problem that affects millions of people around the world each year with an extremely high mortality rate of 30 to
More informationCOPD with Respiratory Failure Case Study #21. Molly McDonough
COPD with Respiratory Failure Case Study #21 Molly McDonough Patient: Mr. Hayato 65 year old male Brought to ER with severe SOB Past History of emphysema Longstanding chronic obstruction pulmonary disease
More informationAECOPD: Management and Prevention
AECOPD: Management and Prevention Neil MacIntyre MD Duke University Medical Center Durham NC AECOPD: Management and Prevention AECOPD: Definitions and impact Acute management of AECOPD Preventing AECOPD.
More informationPulmonary Diseases and Exercise Testing. Pulmonary Diseases COPD. Two Main Types of COPD
Pulmonary Diseases and Exercise Testing Types of Pulmonary Diseases Effect on Exercise Response Role of Exercise in Treatments Pulmonary Diseases Obstructive Restrictive Pulmonary Vascular Diseases Hypo-ventilation
More informationCo-morbiditeit associeert met respiratoire aandoeningen louter omwille van de leeftijd. COPD patiënten hebben veel meer kans op longkanker dan rokers
Academisch centrum huisartsgeneeskunde Pneumologie Juni 2012 Prof W Janssens Co-morbiditeit associeert met respiratoire aandoeningen louter omwille van de leeftijd. COPD patiënten hebben veel meer kans
More informationArterial Blood Gas Case Questions and Answers
Arterial Blood Gas Case Questions and Answers In the space that follows you will find a series of cases that include arterial blood gases. Each case is then followed by an explanation of the acid-base
More informationSMO: Anaphylaxis and Allergic Reactions
REGION I EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS EMT Basic SMO: Anaphylaxis and Allergic Reactions Overview: Allergic reactions can vary in severity from a mild reaction consisting of hives
More informationDocumenting & Coding. Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC
Documenting & Coding Chronic Obstructive Pulmonary Disease (COPD) Presented by: David S. Brigner, MLA, CPC Sr. Provider Training & Development Consultant Professional Profile David Brigner currently performs
More informationWhy Do Some Antibiotics Fail?
Why Do Some Antibiotics Fail? Patty W. Wright, M.D. April 2010 Objective To outline common reasons why antibiotic therapy is not successful and how this can be avoided. And to teach you a little bit about
More informationDevelopment and Implementation of Respiratory Care Plans
wheatley/shutterstock, Inc. CHAPTER Development and Implementation of Respiratory Care Plans David C. Shelledy and Jay I. Peters CHAPTER OUTLINE KEY TERMS Introduction to Respiratory Care Plans Common
More informationAchieving Quality and Value in Chronic Care Management
The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of
More informationRES Non-Invasive Positive Pressure Ventilation Guideline Page 1 of 9
Page 1 of 9 Scope: Respiratory Care Department, Physicians, Advanced Nurse Practitioners (APRN), Physician Assistants (PA) Population: Patients receiving rescue or non-rescue non-invasive positive pressure
More informationRespiratory Care. A Life and Breath Career for You!
Respiratory Care A Life and Breath Career for You! Respiratory Care Makes a Difference At 9:32 am, Lori Moreno brought a newborn baby struggling to breathe back to life What have you accomplished today?
More informationCOPD: Management of Acute Exacerbations and Chronic Stable Disease
COVER ARTICLE PRACTICAL THERAPEUTICS COPD: Management of Acute Exacerbations and Chronic Stable Disease MELISSA H. HUNTER, M.D., and DANA E. KING, M.D. Medical University of South Carolina College of Medicine,
More informationChronic Obstructive Pulmonary Disease
COPD Guideline Team Team Leader Davoren A Chick, MD General Medicine Team Members Paul J Grant, MD General Medicine Meilan K Han, MD, MS Pulmonary Medicine R Van Harrison, PhD Medical Education Elisa B
More informationChronic Obstructive Pulmonary Disease Patient Guidebook
Chronic Obstructive Pulmonary Disease Patient Guidebook The Respiratory System The respiratory system consists of the lungs and air passages. The lungs are the part of the body where gases are exchanged
More informationEvidence-based approach to acute exacerbations of COPD Francisco J. Soto, MD,* and Basil Varkey, MD, FRCP, FCCP
Evidence-based approach to acute exacerbations of COPD Francisco J. Soto, MD,* and Basil Varkey, MD, FRCP, FCCP Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the
More information